Fracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: is there immortal time bias?
Crossref DOI link: https://doi.org/10.1007/s00198-017-4120-2
Published Online: 2017-07-13
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Driessen, J. H. M.
Knapen, L. M.
Geusens, P. P. M. M.
van den Bergh, J. P. W.
License valid from 2017-07-13